Conversely, elevation in MYC levels is associated with IMiD resistance, and CRBN abnormalities, including acquired mutations of CRBN and related genes, have been identified in a portion (22%) of IMiD-resistant MM patients; both CRBN loss and MYC upregulation confer a poor prognosis.15 This evidence concerns the gene CRBN and Miyoshi myopathy.